Question of the Day January 31, 2014 What are compounding pharmacies that do both human and veterinary compounding doing to comply with DQSA? How can they comply with both the outsourcing provision for human compounds but still comply on the veterinary side? Is this an unintended consequences of the DQSA forcing compounding pharmacies that do both to either incur more expense or decide whether they will compound human drugs (as outsourcing facilities) or veterinary drugs in compliance with traditional compounding? Doesn't this suggest Congress needs to take immediate action regarding veterinary compounding and resolve the conflict?